By Colin Kellaher

Edwards Lifesciences Corp. on Thursday said Michael Mussallem, who has been chairman and chief executive of the medical-device maker since its spinoff from Baxter International Inc. in 2000, plans to retire as CEO in May.

The Irvine, Calif., company said Bernard Zovighian, currently corporate vice president and general manager for its transcatheter mitral and tricuspid therapies business, will become president on Jan. 1 and succeed Mr. Mussallem as CEO on May 11 in connection with the annual shareholder meeting.

Edwards said Mr. Mussallem, who recently turned 70, will stand for election as non-executive chairman at the annual meeting.

Mr. Zovighian joined Edwards in 2015.

Write to Colin Kellaher at colin.kellaher@wsj.com

(END) Dow Jones Newswires

December 08, 2022 08:41 ET (13:41 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.
Edwards Lifesciences (NYSE:EW)
Historical Stock Chart
From Mar 2023 to Mar 2023 Click Here for more Edwards Lifesciences Charts.
Edwards Lifesciences (NYSE:EW)
Historical Stock Chart
From Mar 2022 to Mar 2023 Click Here for more Edwards Lifesciences Charts.